Stock Screener
Home
Account
Top Lists
Favorites
Best Portfolios
Screener
Portfolios
News
School
WST - West Pharmaceutical Services, Inc.
$232.34
-4.5% ($-10.42)
5.5
0.2
5.5
6.9
0.2
37.9
4
BP
DE
PE
EPS
ROE
BVPS
CURRENT
Choose a Financial Catagory:
assets
equity
revenues
inventory
liabilities
fixed_assets
gross_profit
net_cash_flow
current_assets
long_term_debt
cost_of_revenue
net_income_loss
accounts_payable
intangible_assets
noncurrent_assets
costs_and_expenses
operating_expenses
current_liabilities
basic_average_shares
other_current_assets
exchange_gains_losses
operating_income_loss
diluted_average_shares
liabilities_and_equity
noncurrent_liabilities
benefits_costs_expenses
other_noncurrent_assets
basic_earnings_per_share
net_cash_flow_continuing
other_operating_expenses
research_and_development
comprehensive_income_loss
other_current_liabilities
diluted_earnings_per_share
income_tax_expense_benefit
other_noncurrent_liabilities
equity_attributable_to_parent
other_comprehensive_income_loss
net_income_loss_attributable_to_parent
net_cash_flow_from_financing_activities
net_cash_flow_from_investing_activities
net_cash_flow_from_operating_activities
income_loss_from_equity_method_investments
selling_general_and_administrative_expenses
income_loss_before_equity_method_investments
equity_attributable_to_noncontrolling_interest
preferred_stock_dividends_and_other_adjustments
comprehensive_income_loss_attributable_to_parent
income_loss_from_continuing_operations_after_tax
income_loss_from_continuing_operations_before_tax
net_cash_flow_from_financing_activities_continuing
net_cash_flow_from_investing_activities_continuing
net_cash_flow_from_operating_activities_continuing
net_income_loss_available_to_common_stockholders_basic
other_comprehensive_income_loss_attributable_to_parent
net_income_loss_attributable_to_noncontrolling_interest
comprehensive_income_loss_attributable_to_noncontrolling_interest
participating_securities_distributed_and_undistributed_earnings_loss_basic
Address:
Portfolio: